Azithromycin (Z-Pack) for Sore Throat
Azithromycin should not be used as first-line treatment for sore throat—penicillin V remains the recommended antibiotic when antibiotics are indicated, but most sore throats should not receive antibiotics at all. 1
When Antibiotics Are NOT Indicated
Do not prescribe antibiotics for patients with 0-2 Centor criteria (fever, tonsillar exudates, tender anterior cervical lymphadenopathy, absence of cough), as the likelihood of bacterial infection is low and antibiotics provide no meaningful benefit. 1, 2
Antibiotics should not be used to prevent rheumatic fever or acute glomerulonephritis in low-risk patients (those without previous history of rheumatic fever), as the absolute risk of these complications is extremely small. 1
Do not prescribe antibiotics to prevent suppurative complications such as quinsy, acute otitis media, cervical lymphadenitis, mastoiditis, or acute sinusitis, as clinicians do not need to treat most cases of acute sore throat to prevent these outcomes. 1
When Antibiotics May Be Considered
For patients with 3-4 Centor criteria, discuss the modest benefits of antibiotics against the risks of side effects, antimicrobial resistance, effect on the microbiota, medicalization, and costs. 1
Antibiotics reduce throat soreness modestly at day 3, but by one week the absolute benefit is minimal. 2
Confirm Group A β-hemolytic streptococcus (GABHS) infection with rapid antigen detection test or throat culture before prescribing antibiotics in patients with 3-4 Centor criteria. 2, 3
First-Line Antibiotic Choice
If antibiotics are indicated after confirmed GABHS infection, penicillin V (twice or three times daily for 10 days) is the recommended first-choice agent. 1
There is not enough evidence that indicates shorter treatment length with penicillin V is adequate. 1
Role of Azithromycin (Z-Pack)
While azithromycin has been studied for streptococcal pharyngitis, the evidence shows important limitations:
Meta-analysis comparing azithromycin with other antibiotics showed it can be effective for GABHS pharyngitis, but it is not recommended as first-line therapy. 1
In pediatric studies, azithromycin (12 mg/kg once daily for 5 days) was clinically and microbiologically superior to penicillin V at Days 14 and 30, with bacteriologic eradication rates of 95% vs. 73% at Day 14. 4
However, approximately 1% of azithromycin-susceptible S. pyogenes isolates became resistant to azithromycin following therapy. 4
Adult studies showed azithromycin (500 mg on day 1, then 250 mg daily for 4 days) achieved 91% GABHS eradication compared to 96% with penicillin V, though this difference was not statistically significant. 5
Gastrointestinal adverse events were significantly more common with azithromycin (16.6%) than penicillin (1.7%). 5
Symptomatic Management (First-Line for All Patients)
- Either ibuprofen or paracetamol (acetaminophen) are recommended for relief of acute sore throat symptoms regardless of whether antibiotics are prescribed. 1, 2
Critical Pitfalls to Avoid
Do not prescribe antibiotics without microbiological confirmation, as clinical features alone cannot reliably distinguish GABHS from viral pharyngitis. 3
Do not test patients with clear viral symptoms (cough, rhinorrhea, conjunctivitis), as this leads to false-positive results in asymptomatic carriers and unnecessary antibiotic use. 3
Delayed antibiotic prescribing is an evidence-based strategy that reduces antibiotic use without increasing complication rates and should be considered for patients with 3-4 Centor criteria. 2
If azithromycin is used (typically reserved for penicillin-allergic patients), recognize that it contributes to antimicrobial resistance and has higher rates of gastrointestinal side effects compared to penicillin. 4, 5